Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endosomal pH refers to the acidic pH environment within endosomes, which is dynamically regulated during endosome maturation and is essential for functions such as cargo degradation, receptor recycling, vesicle trafficking, and cellular signaling[3][4]. Acidification is driven mainly by the vacuolar-type H^+-ATPase (V-ATPase), with additional regulation by Na^+/H^+ exchangers (such as NHE6, NHE9), Na^+/K^+-ATPase, and chloride channels[1][2][4][5][6]. Disruption of endosomal pH homeostasis can result in impaired protein and membrane trafficking, altered cell signaling, and pathophysiological states including neurodegeneration, infection susceptibility, and cancer[6][10]. While pH itself is not a protein or gene, its regulation represents a potential therapeutic strategy by targeting the responsible molecular machinery such as V-ATPase or endosomal Na^+/H^+ exchangers[4][6][10].
Inhibition or alteration of vesicular acidification (e.g. by V-ATPase or Na^+/K^+-ATPase inhibition)[1][4]; Alkalinization of acidic organelles (e.g. by weak bases such as chloroquine)[2][6]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal pH.